newsfilter
← Latest News
GlobeNewswire·

Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th

VANCOUVER, British Columbia, April 25, 2022 (GLOBE NEWSWIRE) -- Filament Health (OTCQB:FLHLF) (NEO:FH) (FSE:7QS), a clinical-stage natural psychedelic drug development company, today announced that Benjamin Lightburn, CEO and Co-Founder, will present